Benzinga's Volume Movers

Pike PIKE shares moved up 48.81% to $11.85. The volume of Pike shares traded was 8987% higher than normal. Pike signed a definitive $12 per share deal to be acquired by its chief executive and a private equity firm. Tekmira Pharmaceuticals TKMR surged 3.09% to $14.70. The volume of Tekmira Pharmaceuticals shares traded 3430% higher than normal. According to a report, the FDA will work with companies developing Ebola drugs. Tower Semiconductor TSEM shares climbed 5.24% to $10.85. The volume of Tower Semiconductor shares traded was 483% higher than normal. TowerJazz reported better-than-expected second-quarter net profit. Durata Therapeutics DRTX shares rose 12.50% to $14.40. The volume of Durata Therapeutics shares traded was 310% higher than normal. Durata Therapeutics is expected to report Q2 financial results on August 7, 2014.